"Cytomegalovirus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.
MeSH Number(s)
B04.280.382.150.150
B04.909.204.382.150.150
Concept/Terms
Cytomegalovirus- Cytomegalovirus
- Cytomegaloviruses
- Salivary Gland Viruses
- Salivary Gland Virus
- Virus, Salivary Gland
- Viruses, Salivary Gland
Below are MeSH descriptors whose meaning is more general than "Cytomegalovirus".
Below are MeSH descriptors whose meaning is more specific than "Cytomegalovirus".
This graph shows the total number of publications written about "Cytomegalovirus" by people in Harvard Catalyst Profiles by year, and whether "Cytomegalovirus" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 2 | 2 |
1995 | 4 | 3 | 7 |
1996 | 2 | 4 | 6 |
1997 | 5 | 3 | 8 |
1998 | 9 | 4 | 13 |
1999 | 7 | 6 | 13 |
2000 | 3 | 6 | 9 |
2001 | 9 | 9 | 18 |
2002 | 8 | 8 | 16 |
2003 | 9 | 5 | 14 |
2004 | 9 | 4 | 13 |
2005 | 5 | 2 | 7 |
2006 | 8 | 4 | 12 |
2007 | 5 | 6 | 11 |
2008 | 8 | 4 | 12 |
2009 | 9 | 8 | 17 |
2010 | 6 | 7 | 13 |
2011 | 10 | 3 | 13 |
2012 | 7 | 6 | 13 |
2013 | 10 | 5 | 15 |
2014 | 12 | 5 | 17 |
2015 | 11 | 6 | 17 |
2016 | 11 | 2 | 13 |
2017 | 7 | 7 | 14 |
2018 | 11 | 4 | 15 |
2019 | 7 | 10 | 17 |
2020 | 15 | 7 | 22 |
2021 | 13 | 15 | 28 |
2022 | 3 | 18 | 21 |
2023 | 7 | 18 | 25 |
2024 | 2 | 7 | 9 |
Below are the most recent publications written about "Cytomegalovirus" by people in Profiles.
-
Immune milestones to predict CMV after letermovir. Blood Adv. 2024 Jun 11; 8(11):2964-2966.
-
Commercial human 3D corneal epithelial equivalents for modeling epithelial infection in herpes keratitis. Virology. 2024 Jul; 595:110096.
-
Unusual isolated cytomegalovirus cutaneous infections: A subtle histopathologic diagnosis with review of the literature. J Cutan Pathol. 2024 Aug; 51(8):565-571.
-
Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIV. J Acquir Immune Defic Syndr. 2024 Apr 15; 95(5):470-478.
-
Cost-effectiveness of maribavir versus conventional antiviral therapies for post-transplant refractory cytomegalovirus infection with or without genotypic resistance: A US perspective. J Med Virol. 2024 Apr; 96(4):e29609.
-
Human otic progenitor cell models of congenital hearing loss reveal potential pathophysiologic mechanisms of Zika virus and cytomegalovirus infections. mBio. 2024 Apr 10; 15(4):e0019924.
-
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients. J Infect Dis. 2024 Feb 14; 229(2):413-421.
-
Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial. Transplantation. 2024 Apr 01; 108(4):e63.
-
Letermovir for Cytomegalovirus infection in pediatric patients undergoing allogenic hematopoietic stem cell transplantation: a real-life study by the Infectious Diseases Working Group of Italian Association of Pediatric Hematology-Oncology (AIEOP). Bone Marrow Transplant. 2024 Apr; 59(4):505-512.
-
QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients. Transplantation. 2024 Apr 01; 108(4):985-995.